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Non-cholesteatomatous suppurative otitis media:
facial nerve palsy in an immunocompromised patient
C. HARTLEY, F.R.C.S., S. R. SAEED, F.R.C.S., T. J. LYONS, M.R.C.PATH.
Abstract
A 47-year-old man developed a complete facial nerve palsy secondary to non-cholesteatomatous suppurative
otitis media. At operation, this was seen to be due to destruction of the nerve from halfway along the horizontal
segment to a point just distal to the second genu. The history of recent renal transplantation and subsequent
immunosuppression was judged to be significant in the pathogenesis of the palsy.
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Introduction
Lower motor neurone facial palsy is a common condition
with an estimated incidence of 20-25 cases per 100 000
population annually (Sherwen and Thong, 1987). The
aetiology of these palsies falls into two broad groups: 50
per cent are idiopathic (Bell's palsy), while in the
remainder, a large group of underlying pathologies can
be demonstrated after appropriate investigation (May,
1987). Amongst this latter group, three to four per cent of
cases are associated with infection in the tympanomastoid
region (Takahashi et al., 1985; May, 1987). In children,
acute suppurative otitis media is the most common
infective cause (May, 1987), though rarely serous otitis
media is responsible (Premachandra and Radcliffe, 1989).
In contrast, in adults, chronic suppurative otitis media
(CSOM) is the more common infective cause. In this adult
group, cholesteatoma is usually present, with exposure of
the facial nerve within its tympanic portion (Takahashi et
al.. 1985: Savic and Djeric, 1989). Less commonly, specific
chronic infections are responsible, such as tuberculosis or
syphilis (De Paep et al, 1989; Linstrom et al, 1993). There
remains, however, a small group of patients with CSOM in
which cholesteatoma and specific infection are both absent.
We present such a case occurring in an immunocompro-
mised patient, in whom aggressive mucosal disease led to a
complete facial palsy.
Case history
A 47-year-old man was referred to the ENT Depart-
ment at Manchester Royal Infirmary shortly after receiving
a cadaveric renal transplant for chronic renal failure
secondary to hypercalcaemia of unknown origin. A
parathyroidectomy was undertaken in the year preceding
the renal transplant. Four months prior to ENT referral, he
developed intermittent right-sided otorrhoea, accompa-
nied by a decrease in hearing on that side. There were no
other symptoms referable to the right ear and no prior
otological history of note, other than a longstanding mixed
hearing loss of unknown origin in the contralateral ear.
Otoscopy of the left ear was normal, while on the right
side, a polyp could be seen obstructing the external canal.
Culture of the mucopurulent discharge grew gentamicin-
sensitive Pseudomonas aeruginosa while histology of the
FIG. 1
Pre-operative appearance of right facial palsy (House
Grade VI).
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Histology of proximal facial nerve stump showing wavy nerve fibres (W). terminating (t) abruptly in dense sclerotic fibrous tissue
(f) containing scattered chronic inflammatory cells (C).
polyp showed granulation tissue. Following aural toilet,
audiometry of the right ear was normal.
The decision to explore the right ear was made, but the
patient experienced an episode of severe rejection of the
renal transplant which required treatment with azathio-
prine, prednisolone and cyclosporin. He was subsequently
lost to ENT follow-up.
Three months later, he was re-admitted by the renal
physicians with a deterioration in renal function and a
three-week history of a complete right lower motor
neurone facial palsy (Figure 1). Following stabilization of
his renal function over the next six weeks, the patient
underwent an exploration of the right mastoid. The polyp
was found to be eroding the posterior and inferior wall of
the deep external meatus. Polypoid tissue filled the middle
ear and had breached the facial canal, destroying the
section of facial nerve from halfway along the horizontal
segment to a point just distal to the second genu. The
incus, malleus and stapes arch had also been destroyed by
the disease process. A radical mastoid cavity was therefore
fashioned. Histology of the polyp and tissue taken from the
mesotympanum revealed active granulation tissue with no
evidence of neoplasia. The cavity continued to discharge
post-operatively and required regular micro-suction and
topical treatment. Five months later, once optimal control
was achieved, the patient underwent re-exploration of the
right ear with repair of the facial nerve using a 15 mm
section of the greater auricular nerve as a cable graft. The
histological appearance of the proximal facial nerve stump
is shown in Figure 2, demonstrating a surrounding chronic
inflammatory cell infiltrate. Subsequent outpatient review
revealed initial return of facial function at nine months and
when last reviewed, some 12 months after the nerve graft.
facial nerve function had improved to House Grade IV
(Figure 3).
Discussion
Facial palsy due to CSOM without cholesteatoma is
rare. Such palsies are more frequent when cholesteatoma
is present and unless a congenital dehiscence of the
fallopian canal exists, must be preceded by a period of
bone erosion. The pathogenesis of bone resorption in
cholesteatoma is complex, and may involve more than one
mechanism. Pressure from a cholesteatomatous sac may
induce osteoclastic activity and lead to dehiscence of a
portion of bone over the nerve (Chole. 1988). leading to a
slowly progressive facial weakness (McGinn et al. f986).
However, acquired cholesteatoma is usually associated
with granulation tissue and infection (Djeric and Savic.
1989), with a number of interlinking mechanisms at the
cellular and enzymatic level being responsible for bone
resorption. Interleukin-I (IL-I) released from tissue
macrophages increases local osteoclast activity and is
chemotactic for circulating monocytes and macrophaees
(Ahn etal, 1990; Schilling et al. 1992). The rapid growtrTof
squamous epithelium, enhanced by the presence of
infection (Wells and Michaels. 1991). leads to high
numbers of desquamated cells which may further accel-
erate osteoclastic activation by release of IL-I (Schilling et
al. 1992). Cells of the macrophage/monocyte series may
also exhibit osteoclast-like activity, especially if stimulated
by cytokines released from polymorphonuclear leucocytes
(Maylot el al. 1991). Interleukin-I is also known to
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FIG. 3
Post-operative appearance of right facial palsy at 12 months
(House Grade IV).
stimulate increased production of collagenase and pros-
taglandin E2 (PGE2), both of which are produced by
bone-resorbing cells (Ahn et al, 1990). Recently, a
parathyroid-hormone-like substance has been isolated
from cholesteatomata, suggesting a more direct mechan-
ism for bone resorption (Cheshire et al, 1991). Osteoclastic
bone resorption may lead to dehiscence of the fallopian
canal (Browning, 1987), with subsequent facial paralysis as
the infective process involving the facial nerve trunk
(Djeric and Savic, 1990). Granulation tissue in association
with longstanding infection may lead to polyp formation,
impeding drainage via the external auditory meatus and
further exacerbating the condition.
Thomsen and his colleagues in their extensive histolo-
gical and histochemical studies on CSOM, noted that bone
resorption occurred whether or not cholesteatoma was
present: however, the magnitude of the resorption was
greater when cholesteatoma was present (Thomsen et al.
1974; 1981). In cases of non-cholesteatomatous CSOM,
many of the factors which precipitate bone resorption still
apply. PGE2 has been demonstrated in middle ear
granulation tissue to have a similar level of bone resorbing
activity to that in cholesteatoma (Kurihara et al, 1991).
Infection will activate cells of the polymorph and
monocyte/macrophage series whether cholesteatoma is
present or not. However, the desquamating cells in
cholesteatoma undoubtedly accelerate the immune activa-
tion, which may explain the more extensive bone
resorption when cholesteatoma is present.
In the case we describe, the disease process was so
aggressive as to completely destroy a 15 mm section of
fallopian canal and facial nerve and therefore the
possibilities of malignancy or tuberculous otitis media
were considered. However, histopathology and microbiol-
ogy of tissue obtained at the time of operation were
negative. In view of the onset of facial palsy during
treatment for acute graft rejection, it is likely that the
Pseudomonas aeruginosa infection secondary to the
patient's compromised immune status was primarily
responsible for the extensive nature of the mucosal
disease. This may have led to a necrotizing vasculitis,
osteitis and neuritis, much as is seen in malignant otitis
externa. However, the possibility that hyperparathyroid-
ism enhanced the osteoclastic activity also has to be
considered.
Despite the creation of an adequately ventilated radical
mastoid cavity, there was persistence of granulation tissue
and infection which delayed repair of the facial nerve. This
granulation tissue was difficult to eradicate until the
immunosuppressants were returned to maintenance
levels. The treatment of facial palsy secondary to chronic
mucosal otitis media, as when cholesteatoma is present, is
surgical. The ear must be explored as soon after the onset
of the palsy as possible, with removal of diseased mucosa
and creation of adequate drainage and ventilation. To
achieve this, open cavity mastoidectomy is frequently
necessary (Harker and Pignatari, 1992). With such
treatment, the majority of patients can expect complete
recovery of facial nerve function, though partial recovery
and persistent paralysis have been documented (Savic and
Djeric, 1989; Harker and Pignatari. 1992).
Conclusion
This report describes a case of non-cholesteatomatous
facial palsy. Unlike previous reports, the palsy was
secondary to complete destruction of a significant segment
of the nerve. The extensive nature of the mucosal disease,
coincidence with an episode of severe graft rejection
suggests that the immunosuppression was significant in the
pathogenesis of the facial palsy.
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